Cementless Total Hip Replacement for the Management of Severe Developmental Dysplasia of the Hip in the Middle Eastern Population: A Prospective Analysis

In the Middle East, severe developmental dysplasia of the hip with subsequent high dislocation is often seen. We assessed the efficiency of total hip replacement (THR) with subtrochanteric shortening femoral osteotomy and trochanteric advancement in this population. This prospective study assessed 2...

Full description

Saved in:
Bibliographic Details
Published inFrontiers in surgery Vol. 3; p. 31
Main Authors Imam, Mohamed A, Fathalla, Ismail, Holton, James, Nabil, Mohamed, Kashif, Fadhil
Format Journal Article
LanguageEnglish
Published Switzerland Frontiers Media S.A 30.05.2016
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:In the Middle East, severe developmental dysplasia of the hip with subsequent high dislocation is often seen. We assessed the efficiency of total hip replacement (THR) with subtrochanteric shortening femoral osteotomy and trochanteric advancement in this population. This prospective study assessed 25 female patients with symptomatic and severe (Crowe IV). Pre- and postoperative Harris hip score (HHS) and Oxford hip score (OHS) were performed alongside assessment of leg length discrepancy (LLD) and the ability to sit in a cross-legged position. The mean HHS and OHS improved pre-operatively at 1 and 10 years, respectively (p-value < 0.001). The mean postoperative LLD was 3 mm (0-8 mm). Functionally, 22/25 patients were able to sit cross-legged. None of the 25 hips underwent revision during this period. Total hip replacement with subtrochanteric shortening osteotomy in combination with trochanteric advancement is sufficient for the management of Crowe type IV hips in this population.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Specialty section: This article was submitted to Orthopedic Surgery, a section of the journal Frontiers in Surgery
Edited by: Hannes A. Rüdiger, Schulthess Clinic, Switzerland
Reviewed by: Paul Simon Unwin, Stanmore Implants Worldwide Ltd, UK; Konstantinos Markatos, Henry Dunant Hospital Center, Greece
ISSN:2296-875X
2296-875X
DOI:10.3389/fsurg.2016.00031